Recombinant vaccines and use thereof

Details for Australian Patent Application No. 2004282332 (hide)

Owner BioNTech AG

Inventors Kreiter, Sebastian; Sahin, Ugur; Tureci, Ozlem

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004282332

PCT Pub. Number WO2005/038030

Priority 103 47 710.1 14.10.03 DE

Filing date 13 October 2004

Wipo publication date 28 April 2005

Acceptance publication date 20 May 2010

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/74 (2006.01) Peptides having more than 20 amino acids

Event Publications

4 May 2006 PCT application entered the National Phase

  PCT publication WO2005/038030 Priority application(s): WO2005/038030

28 May 2009 Assignment before Grant

  Johannes Gutenberg-Universitat Mainz, vertreten durch den Prasidenten The application has been assigned to BioNTech AG

20 May 2010 Application Accepted

  Published as AU-B-2004282332

16 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004282334-Industrial furnace and associated jet element

2004282274-Method and device for determining the actual position of a geodetic instrument